From Clinical to Commercial – The Challenges of a Scaling-Up Biopharmaceutical CDMO

• Manufacturing et qualité
• /
• Pharmacie et Sciences de la vie
• /
• Article

CDMOs assist biopharmaceutical companies in creating the process development and the manufacturing cycle from start to finish. What are the obstacles that stand in the way of CDMOs from scaling-up?

Patent Loss – What to Expect and How to Prepare

• Stratégie (Corporate)
• /
• Pharmacie et Sciences de la vie
• /
• Article

How can a pharmaceutical company prepare for the day after its branded drug patent loss?

How to Launch a Network Wide Continuous Improvement Program

• Opérations et Organisation
• /
• Pharmacie et Sciences de la vie
• /
• Case Studies

A pharmaceutical distribution company sought to initiate a Continuous Improvement program throughout their entire Distribution Center network, focusing on Quality, Efficiency, Self-sufficiency and Embedment of CI culture.

How to Manage Innovative Healthcare Solution Tenders?

• Stratégie (Corporate)
• /
• Pharmacie et Sciences de la vie
• /
• Case Studies

Tefen supported and helped a medical device company win a tender

Lean Internal Auditing and Response Mechanisms for Life Sciences

• Manufacturing et qualité
• /
• Pharmacie et Sciences de la vie
• /
• Article

This article explains the different approaches and cost benefits toward quality and audit management programs in today’s regulatory world in the Life Sciences industry

Compliance Under the Radar – Little Recognition, Big Problem

• Manufacturing et qualité
• /
• Pharmacie et Sciences de la vie
• /
• Article

The article discusses best practices approach towards reaching optimized compliancy in the life sciences industry.

Effective and Efficient Enterprise Risk Management in Life Sciences

• Manufacturing et qualité
• /
• Pharmacie et Sciences de la vie
• /
• Article

This article will explore synergies to be gained by optimizing both technology and management practices to create a stronger, more effective risk mitigation program.

Multichannel Sales and Marketing in Life Sciences: A Paradigm Shift or Natural Evolution?

• Marketing, ventes
• /
• Pharmacie et Sciences de la vie
• /
• Tribune

Launching a Continuous Improvement Program in any organization

• Opérations et Organisation
• /
• Pharmacie et Sciences de la vie
• /
• Tribune

As technological advances change the way society thinks and acts many organizations are working harder without gaining a competitive advantage.

Life Sciences - a Journey to Pricing Excellence

• Marketing, ventes
• /
• Pharmacie et Sciences de la vie
• /
• Article

The pressure on Healthcare budgets is placing Pricing on top of most Life Sciences leaders’ agendas. Tefen provides pricing expertise for our clients.

Risk Mitigation, from a Commercial Excellence Perspective

• Marketing, ventes
• /
• Pharmacie et Sciences de la vie
• /
• Article

Pharmaceutical legal departments today juggle many risks for their companies and risk mitigation will continue to grow in complexity and importance.

Pharma Supply Chain Planning — Reliability and Risk Management

• Stratégie (Corporate)
• /
• Pharmacie et Sciences de la vie
• /
• Tribune

New challenges, larger global markets, and growing complexity are stressing the need for supply chain planning and risk management in the pharma industry

Reducing Lead Times for a Large Generic Drug Manufacturer

• Manufacturing et qualité
• /
• Pharmacie et Sciences de la vie
• /
• Case Studies

Minimizing changeovers and maximizing flexibility to market demands – the challenge of reducing lead times for a large generic drug manufacturer

Pharmaceutical Manufacturing - Pathways to Continuous Improvement

• Manufacturing et qualité
• /
• Pharmacie et Sciences de la vie
• /
• Article

Operational excellence requires a deep commitment and a culture of change. A recent survey shows where pharmaceutical manufacturers stand on the path.

Capacity Improvement in a Pharmaceutical Manufacturing Company

• Manufacturing et qualité
• /
• Pharmacie et Sciences de la vie
• /
• Case Studies

A big pharmaceutical firm, specializing in generics and drug delivery engaged Tefen to increase capacity in their existing operations using lean methodologies.

Bridging the Gap between Prescriptions and Sales

• Marketing, ventes
• /
• Pharmacie et Sciences de la vie
• /
• Tribune

Treatments supported by sound sales & maximize prescription shares for pharmaceutical products. But is that enough to unfold a drug's full revenue potential?

TEVA: The Way to Become a Leader in The Pharmaceutical Market

• Stratégie (Corporate)
• /
• Pharmacie et Sciences de la vie
• /
• Tribune

Swooping on opportunities and making daring moves. Israel Makov, president and CEO during critical years, explains how Teva grew into a world power

Dilemma of leading companies in the young biotech market

• Stratégie (Corporate)
• /
• Pharmacie et Sciences de la vie
• /
• Tribune

Biotech companies contend with unique circumstances yet share many of the problems of broad industry. Benchmarking can be a tool to focus on the real key issues

Lean 360 in the Eyeglasses Lens Sector

• Manufacturing et qualité
• /
• Pharmacie et Sciences de la vie
• /
• Tribune

How implementation of Tefen’s “LEAN 360” approach can help us shorten the lead time on producing and delivering lenses in order to get competitive advantage

Creating Standardization Using CAPA Model for Global Operations

• Opérations et Organisation
• /
• Pharmacie et Sciences de la vie
• /
• Case Studies

Tefen helped leading standardization and implementation processes throughout the company's global operations using the CAPA model and process re-engineering